Post diploma,paper 2 1. resuscitation in pregnant women , surviving sepsis guidlines 2. lft and their significane, child pugh score 3. usg guided adductor canal block, renal replacement therapy 4. types of labour analgesia, pain pathway in labour pain 5. anaesthesia challenges and mgt of posterior fossa tumour 6. airway management of maxillofacial trauma plus manual inline stabilization 7. anaesthesia mgt of 2 year old paediatric who has foreign body insertion taken for emergency 8. biochemical changes of stored blood, indication and complication of blood transfusion 9. link 25, electrical safety of OT 10. post op analgesia for paediatric in lower abdominal surgery and thoracotomy Answer these question for dnb anaesthesia exam take from genuine source like miller morgon stoeiltinng etc
You are a DNB Anaesthesia exam expert. Research the following 5 topics from the medical library database and provide comprehensive exam-ready answers. Use query_library_db to search, then read the relevant file sections. TOPICS TO RESEARCH: 1. **Resuscitation in pregnant women** - CPR modifications in pregnancy, left lateral tilt, perimortem caesarean section (within 5 minutes), ACLS in pregnancy, airway management, defibrillation in pregnancy 2. **Surviving Sepsis Guidelines** - Hour-1 bundle, fluid resuscitation (30ml/kg crystalloid), vasopressors (norepinephrine first line), antibiotics (within 1 hour), lactate measurement, source control, corticosteroids in refractory septic shock, ventilation targets 3. **Liver Function Tests and their significance** - ALT, AST, ALP, GGT, bilirubin (direct/indirect), albumin, PT/INR, total protein - normal values and clinical significance, pattern of liver disease (hepatocellular vs cholestatic) 4. **Child-Pugh score** - Parameters (bilirubin, albumin, PT, ascites, encephalopathy), scoring (1-3 for each), Class A/B/C, anaesthetic significance, surgical risk assessment 5. **Types of labour analgesia + Pain pathway in labour pain** - First stage pain (T10-L1, visceral), second stage pain (S2-S4, somatic), epidural analgesia technique, CSE, spinal, systemic opioids (entonox, remifentanil PCA), paracervical block, pudendal block. Include dermatomal levels. SEARCH INSTRUCTIONS: - Use headings_fts and paragraphs_fts to find relevant sections - Read the actual file content using read_file - Cite specific textbooks (Miller's Anaesthesia, Morgan & Mikhail, Stoelting, etc.) - Provide comprehensive exam-oriented answers with key points, tables where appropriate Return a detailed, structured answer for ALL 5 topics suitable for a DNB Post-Diploma Paper 2 exam.
You are a DNB Anaesthesia exam expert. Research the following 5 topics from the medical library database and provide comprehensive exam-ready answers. Use query_library_db to search, then read the relevant file sections. TOPICS TO RESEARCH: 1. **USG-guided adductor canal block** - Anatomy (subsartorial canal, saphenous nerve, VMCN, nerve to vastus medialis), probe position (mid-thigh), sonoanatomy, technique, volume/drug, indications (TKR), advantages over femoral nerve block (preserved quadriceps strength), complications 2. **Renal Replacement Therapy (RRT)** - Indications (AEIOU: acidosis, electrolytes, intoxication, overload, uremia), types (IHD, CRRT - CVVH/CVVHD/CVVHDF), anticoagulation (heparin, citrate), timing of initiation, KDIGO criteria, differences between modalities, dose recommendations 3. **Anaesthesia challenges and management of posterior fossa tumour** - Sitting vs prone positioning, venous air embolism (VAE) - detection (precordial doppler, TEE, ETCO2 drop), treatment of VAE, ICP management, brainstem monitoring, IONM, specific concerns (facial nerve, IX/X/XI/XII monitoring), emergence/extubation concerns, postoperative complications 4. **Airway management of maxillofacial trauma + Manual Inline Stabilisation (MILS)** - Assessment (airway obstruction risk, haemorrhage, trismus, C-spine precaution), RSI vs awake FOI, MILS technique (does not apply traction), worsening of laryngoscopy grade with MILS, alternatives (videolaryngoscopy, surgical airway), cricothyroidotomy, retrograde intubation, specific fractures (mandible, Le Fort I/II/III, panfacial) 5. **Biochemical changes of stored blood + Indications and complications of blood transfusion** - Storage lesion: pH decrease, K+ increase (up to 30 mEq/L), 2,3-DPG decrease (left shift oxyhb curve), decreased ATP, microaggregates, citrate toxicity. Indications: Hb trigger (7g/dL ICU, 8g/dL cardiac surgery), massive transfusion. Complications: TRALI, TACO, FNHTR, allergic reactions, transfusion-transmitted infections, hypocalcaemia, hypothermia, dilutional coagulopathy SEARCH INSTRUCTIONS: - Use headings_fts and paragraphs_fts to find relevant sections - Read the actual file content using read_file - Cite specific textbooks (Miller's Anaesthesia, Morgan & Mikhail, Stoelting, etc.) - Provide comprehensive exam-oriented answers with key points, tables where appropriate Return a detailed, structured answer for ALL 5 topics suitable for a DNB Post-Diploma Paper 2 exam.
You are a DNB Anaesthesia exam expert. Research the following 3 topics from the medical library database and provide comprehensive exam-ready answers. Use query_library_db to search, then read the relevant file sections. TOPICS TO RESEARCH: 1. **Anaesthesia management of 2-year-old with foreign body (emergency)** - Preoperative assessment (NPO status - full stomach in emergency, type of foreign body, location), induction technique (inhalational vs IV - debate), maintaining spontaneous ventilation vs controlled, rigid bronchoscopy technique (Venturi jet ventilation vs spontaneous), use of sevoflurane, dexmedetomidine, propofol TIVA, airway equipment (sizes for 2-year-old: ETT 4.5 uncuffed, LMA size 2, blade size 1), specific concerns (hypoxia, complete obstruction during manipulation), post-op laryngospasm, stridor, subglottic oedema treatment (nebulised adrenaline, dexamethasone) 2. **Link 25 (Lanz connection) + Electrical safety of operating theatre** - Lanz 25/Link 25: Anaesthetic gas machine safety - pin index system, pressure regulators, fail-safe mechanisms. Electrical safety: macroshock vs microshock, current thresholds (fibrillation at 100mA external, 180 microA internal), isolated power supply, line isolation monitor, equipotential earthing, Class I/II/III equipment, residual current device (RCD/GFCI), anti-static precautions, explosion-proof requirements 3. **Postoperative analgesia for paediatric patients - lower abdominal surgery and thoracotomy** - Lower abdominal: caudal epidural (0.25% bupivacaine 1ml/kg), TAP block (USG-guided, 0.25% bupivacaine 0.5ml/kg), ilioinguinal/iliohypogastric nerve block, wound infiltration. Thoracotomy: thoracic epidural (gold standard, T4-T6 level), paravertebral block (USG-guided PVB), intercostal nerve blocks, PECS block, serratus anterior block, cryoanalgesia. Include drug doses for paediatric patients and age-specific considerations. SEARCH INSTRUCTIONS: - Use headings_fts and paragraphs_fts to find relevant sections - SQL examples: SELECT title, book_title, '/textbooks/' || block_file_path AS file_path, line_number, para_line_ranges FROM headings_fts WHERE headings_fts MATCH 'foreign body bronchoscopy' ORDER BY rank LIMIT 5 SELECT book_title, section_heading, '/textbooks/' || block_file_path AS file_path, line_start, line_end, snippet(paragraphs_fts, 0, '>>>', '<<<', '...', 30) as snippet FROM paragraphs_fts WHERE paragraphs_fts MATCH 'electrical safety microshock' ORDER BY rank LIMIT 5 - Read the actual file content using read_file with appropriate offset and limit - Cite specific textbooks (Miller's Anaesthesia, Morgan & Mikhail, Stoelting, Paediatric Anaesthesia texts) - Provide comprehensive exam-oriented answers Return a detailed, structured answer for ALL 3 topics suitable for a DNB Post-Diploma Paper 2 exam.
What happened
| System | Change | Relevance to CPR |
|---|---|---|
| Cardiac output | ↑ 40–50% | Higher baseline demand |
| Blood volume | ↑ 40–50% | More blood loss needed before haemodynamic compromise |
| Aortocaval compression | Uterus compresses IVC from 20 weeks | ↓ venous return → ↓ CPR effectiveness in supine position |
| Airway | Oedema, friable mucosa, ↑ Mallampati | Difficult intubation; smaller ETT (6.5–7.0 mm) |
| FRC | ↓ 20% | Rapid desaturation; pre-oxygenate aggressively |
| Gastric emptying | Delayed | Full stomach — RSI mandatory |
| O₂ consumption | ↑ 20% | Faster desaturation during apnoea |
| Standard ACLS | Modification in Pregnancy |
|---|---|
| Supine position | Left Uterine Displacement (LUD): 15–30° left tilt OR manual LUD by assistant pushing uterus leftward |
| IV access | Place above diaphragm (antecubital or above) — IVC compression may impair drug delivery from lower limb access |
| Defibrillation | Same energy as non-pregnant (200J biphasic); place pads in standard position; remove fetal monitors first |
| Compression depth | Same (5–6 cm) — may be harder due to breast tissue; use heel of hand |
| Airway | Early intubation (RSI); smaller ETT 6.5–7.0; video laryngoscope first line; Grade I–IV cricothyrotomy for CICO |
| Drugs | Standard ACLS drugs — epinephrine, amiodarone used as per standard protocol; do not withhold due to pregnancy |
| ROSC | Post-ROSC care: oxygen targets, targeted temperature management; fetal monitoring |
"Successful resuscitation of the pregnant patient... requires performance of PMCS within 5 minutes of cardiac arrest onset... The primary indication for PMCS is to relieve aortocaval compression and improve CPR effectiveness for the mother." — Miller's Anesthesia 10e
| Step | Action |
|---|---|
| 1. Measure lactate | If lactate >2 mmol/L → measure serial lactates; target normalisation |
| 2. Blood cultures | Obtain before antibiotics (2 sets — aerobic + anaerobic) |
| 3. Broad-spectrum antibiotics | Administer within 1 hour of recognition |
| 4. IV fluids | 30 mL/kg crystalloid (normal saline or Ringer's lactate) bolus for hypotension or lactate ≥4 mmol/L |
| 5. Vasopressors | If MAP <65 mmHg during/after fluids → norepinephrine first line |
| Agent | Role | Dose |
|---|---|---|
| Norepinephrine | First line | 0.01–3 mcg/kg/min |
| Vasopressin | Add second to ↓ norepinephrine dose | 0.03 units/min fixed |
| Epinephrine | Third line OR when cardiac dysfunction present | 0.01–0.3 mcg/kg/min |
| Dopamine | NOT recommended routinely | Only if bradycardia with low CO |
| Dobutamine | When myocardial dysfunction with low CO | 2–20 mcg/kg/min |
| Test | Normal Value | Significance |
|---|---|---|
| ALT (Alanine aminotransferase) | 7–40 U/L | Most specific for hepatocellular damage; predominantly hepatic; markedly ↑ in viral hepatitis, drug toxicity |
| AST (Aspartate aminotransferase) | 10–40 U/L | Less specific (also in muscle, heart, kidney); ↑ in hepatocellular damage, MI, muscle disease |
| AST:ALT ratio | <1 normally | >2:1 = alcoholic hepatitis (De Ritis ratio); >3:1 strongly suggests alcohol; <1 = viral/NAFLD |
| LDH | 100–200 U/L | Non-specific; ↑ in haemolysis, liver disease, malignancy |
| Test | Normal Value | Significance |
|---|---|---|
| ALP (Alkaline phosphatase) | 30–120 U/L | ↑↑ in cholestasis, biliary obstruction, infiltrative liver disease; also ↑ in bone disease (Paget's, bone metastases), pregnancy |
| GGT (Gamma-glutamyltransferase) | 5–55 U/L | Confirms hepatic origin of ↑ALP (bone disease does NOT ↑GGT); ↑ by alcohol, drugs (phenytoin, rifampicin); most sensitive indicator of alcohol use |
| Bilirubin (total) | <17 μmol/L | Jaundice apparent when >35 μmol/L |
| → Direct (conjugated) | <4 μmol/L | ↑ in cholestasis, hepatocellular disease; water-soluble, excreted in urine → dark urine |
| → Indirect (unconjugated) | <12 μmol/L | ↑ in haemolysis, Gilbert's syndrome, Crigler-Najjar; not water-soluble |
| Test | Normal Value | Significance |
|---|---|---|
| Albumin | 35–50 g/L | Best marker of chronic liver synthetic function; t½ = 20 days; ↓ in cirrhosis, malnutrition, nephrotic syndrome; does NOT reflect acute liver failure |
| PT/INR | PT 11–14 sec; INR <1.2 | Reflects acute synthetic function (factors II, VII, IX, X — Vit K dependent; factor V — not Vit K dependent); best marker in acute liver failure; ↑ INR in liver failure AND Vit K deficiency (differentiate: give Vit K — corrects if deficiency, not if liver failure) |
| Total protein | 60–80 g/L | ↓ in severe liver disease; includes albumin + globulins |
| Pattern | ALT/AST | ALP/GGT | Bilirubin | Albumin | PT |
|---|---|---|---|---|---|
| Hepatocellular | ↑↑↑ | Normal or mild ↑ | ↑ | ↓ (chronic) | ↑ |
| Cholestatic | Mild ↑ | ↑↑↑ | ↑↑ (direct) | Normal | Normal |
| Cirrhosis | Mild ↑ | ↑ | ↑ | ↓↓ | ↑↑ |
| Alcoholic hepatitis | ↑ (AST>ALT, ratio >2) | ↑ GGT | ↑ | ↓ | ↑ |
| Haemolysis | Normal | Normal | ↑ (indirect) | Normal | Normal |
| Parameter | 1 point | 2 points | 3 points |
|---|---|---|---|
| Bilirubin (μmol/L) | <34 | 34–50 | >50 |
| Albumin (g/L) | >35 | 28–35 | <28 |
| PT prolongation (seconds above normal) | <4 | 4–6 | >6 |
| Ascites | None | Mild (diuretic-controlled) | Moderate–severe (tense) |
| Hepatic encephalopathy | None | Grade I–II | Grade III–IV |
| Class | Total Score | Surgical Mortality | 1-year survival | 2-year survival |
|---|---|---|---|---|
| A (compensated) | 5–6 | 5–10% | 100% | 85% |
| B (significant compromise) | 7–9 | 25–30% | 80% | 60% |
| C (decompensated) | 10–15 | 70–80% | 45% | 35% |
| Class | Key Concerns | Anaesthetic Approach |
|---|---|---|
| A | Minimal compromise | Standard anaesthesia; monitor LFTs post-op |
| B | Coagulopathy, ↓ albumin, mild portal hypertension | Avoid hepatotoxic drugs; minimise hepatic blood flow disruption; cautious fluid; check clotting pre-op |
| C | Severe: encephalopathy, ascites, varices, coagulopathy, hepatorenal syndrome risk | High-risk; multidisciplinary planning; regional preferred if coagulation allows; ICU post-op; avoid GA if possible |
| Wall | Structure |
|---|---|
| Roof (anteromedial) | Sartorius muscle + vastoadductor membrane |
| Lateral | Vastus medialis |
| Posteromedial floor | Adductor longus → adductor magnus |
| Step | Detail |
|---|---|
| Position | Supine, thigh externally rotated, leg extended |
| Probe | High-frequency linear (10–15 MHz), transverse orientation |
| Level | Mid-thigh (midpoint ASIS to superior patellar pole) |
| Approach | In-plane, lateral-to-medial |
| Target | Deep to sartorius, lateral to SFA, deep to vastoadductor membrane |
| Volume | 15–20 mL |
| Drug | Ropivacaine 0.5% or Bupivacaine 0.5% ± dexamethasone |
| Aspiration | Mandatory before injection (SFA and SFV adjacent) |
| Feature | ACB | FNB |
|---|---|---|
| Quadriceps strength | Preserved (motor-sparing) | Significantly reduced |
| Ambulation Day 1 | Earlier, safer mobilisation | Limited by quad weakness |
| Fall risk | Lower | Higher |
| Analgesia for TKR | Non-inferior | Excellent but costly (motor block) |
"Patients with continuous adductor canal catheters are able to ambulate further on the first day following total knee arthroplasty than patients with femoral block." — Morgan & Mikhail 7e
| Letter | Indication | Threshold |
|---|---|---|
| A | Metabolic Acidosis | pH <7.1 refractory to medical therapy |
| E | Electrolytes | Hyperkalemia K⁺ >6.5 mEq/L refractory to medical Rx; severe hyponatremia |
| I | Intoxication | Dialyzable toxins: lithium, salicylates, methanol, ethylene glycol, theophylline |
| O | Fluid Overload | Pulmonary oedema refractory to diuretics; oliguria/anuria |
| U | Uraemia | BUN >100 mg/dL symptomatic (encephalopathy, pericarditis, platelet dysfunction) |
| Modality | Mechanism | Duration | Haemodynamics | Best For |
|---|---|---|---|---|
| IHD (Intermittent Haemodialysis) | Diffusion | 3–4 h, 3×/week | Needs stability (risk of intradialytic hypotension) | Stable outpatients |
| SLED/PIRRT | Slow diffusion | 6–18 h/day | Better tolerated than IHD | Intermediate stability |
| CVVH | Convection only | 24 h continuous | Excellent for instability | ICU, haemodynamic compromise |
| CVVHD | Diffusion only | 24 h continuous | Excellent | ICU |
| CVVHDF | Diffusion + Convection | 24 h continuous | Excellent | Optimal solute clearance in ICU |
| PD | Peritoneal diffusion | Continuous | Safe | Limited access settings, children |
| IHD | CRRT | |
|---|---|---|
| Solute clearance | Rapid, fluctuating | Slow, steady |
| Volume removal | Rapid | Gradual, precise |
| Vasopressors | Contraindicated | Compatible |
| Drug clearance | Unpredictable | Predictable, continuous |
| Cost | Lower | Higher |
| Stage | Nerve Fibres | Dermatomes |
|---|---|---|
| 1st stage | Visceral (C fibres) | T10 – L1 |
| 2nd stage | Somatic (Aδ via pudendal) | S2 – S4 |
| Complete epidural analgesia | — | T10 – S4 |
| Drug | Route | Notes |
|---|---|---|
| Entonox (50% N₂O + 50% O₂) | Inhalational self-administered | Fast onset/offset; reduces pain perception 30–40%; nausea, dizziness; bone marrow (chronic use); methionine synthetase inhibition |
| Remifentanil PCA | IV bolus (20–40 mcg, lock-out 2 min) | Ultra-short acting (t½ 3–4 min); effective; risk of apnoea → continuous SpO₂, 1:1 midwife monitoring mandatory |
| Pethidine (Meperidine) | IM 75–100 mg | Widely used; metabolite norpethidine — neonatal respiratory depression; nausea common; 4-hour window before delivery advised |
| Fentanyl | IV/IM | Rapid onset; minimal neonatal accumulation vs pethidine |
| Nalbuphine, Butorphanol | IV/IM | Mixed agonist-antagonist; ceiling effect; nausea |
| Monitor | Sensitivity | Comment |
|---|---|---|
| TEE | Highest (0.02 mL/kg) | Detects PFO; PAE visible; cardiac function; expensive/invasive |
| Precordial Doppler | Very high (0.25 mL) | Standard of care; non-invasive; hissing → roaring sound |
| ETCO₂ | Moderate | Sudden ↓ ETCO₂ = ↑ dead space (dilution by air) |
| Pulmonary artery pressure | Moderate | PAP rises with air embolism |
| CVP | Late | Rises late |
| BP/ECG/Mill-wheel murmur | Very late | Only massive embolism |
⚠️ PEEP is CONTRAINDICATED — reverses RA–LA pressure gradient → increases PAE risk through PFO
| Intervention | Effect |
|---|---|
| Head-up 15–30° | ↓ ICP, ↑ venous drainage |
| PaCO₂ target 35 mmHg | Moderate hyperventilation for brain relaxation |
| Mannitol 0.5–1 g/kg | Osmotic agent; onset 30 min; duration 4–6 h |
| Hypertonic saline (3–23.4%) | Osmotic; maintain Na 145–155 mEq/L |
| Dexamethasone | Reduces peritumoral vasogenic oedema (not cytotoxic) |
| Avoid N₂O | Expands pneumocephalus; worsens VAE |
| Maintain CPP >60 mmHg | CPP = MAP − ICP |
| EVD | For obstructive hydrocephalus |
| Modality | What Monitored | Anaesthetic Constraint |
|---|---|---|
| SSEPs | Dorsal column / sensory pathway | Volatile agents ↓ amplitude dose-dependently |
| MEPs | Corticospinal tract | No NMB (or constant partial block <5% twitch); volatile ↑ latency |
| BAERs | Acoustic nerve, brainstem auditory pathway | Least affected by anaesthesia |
| CN VII EMG | Facial nerve | Critical for acoustic neuroma; absolutely no NMB |
| CN IX/X EMG | Glossopharyngeal/vagus | Swallowing/airway |
| CN XII EMG | Hypoglossal | Tongue/airway post-op |
| Fracture | Description | Airway Implication |
|---|---|---|
| LeFort I | Horizontal fracture, maxilla above nasal floor | Oral intubation preferred |
| LeFort II | Pyramidal; may involve cribriform plate | ⚠️ Nasal intubation contraindicated |
| LeFort III | Craniofacial dysjunction; "dish face" | ⚠️ Nasal intubation absolutely contraindicated — ETT may enter cranium |
| Panfacial | Combined mandible + midface + frontal | Tracheostomy often required |
MAXILLOFACIAL TRAUMA
↓
Can oxygenate/ventilate? → NO → EMERGENCY SURGICAL AIRWAY (cricothyroidotomy)
↓ YES
Anticipated difficult airway?
↓ YES → AWAKE technique (Awake FOI / Awake VL / Awake surgical airway)
↓ NO
RSI + MILS + Videolaryngoscope (preferred over DL)
"MILS does not apply traction — it provides neutral alignment. Traction would worsen an unstable injury."
| Technique | Indication | Notes |
|---|---|---|
| Videolaryngoscopy | RSI + MILS | First choice post-RSI; GlideScope, C-MAC, McGrath |
| Awake fibreoptic (AFOI) | Predicted difficult, C-spine injury | Oral approach (LeFort II/III → no nasal FOI); topical LA + dexmedetomidine |
| Cricothyroidotomy | CICO (cannot intubate, cannot oxygenate) | Scalpel-bougie-tube (SAFELY technique); 4 mm ID minimum |
| Retrograde intubation | Difficult oral access, no FOB | Wire via cricothyroid → oral/nasal exit → guide ETT |
| Tracheostomy | Panfacial, laryngotracheal disruption, long-term | Awake under LA; convert emergency cric within 24–72h |
| Equipment | Size |
|---|---|
| ETT (uncuffed) | 4.5 mm ID (age/4 + 4 = 4.5) |
| ETT (cuffed) | 4.0 mm |
| LMA | Size 2 (10–20 kg) |
| Laryngoscope blade | Miller 1 (straight, preferred for infant/toddler) |
| Rigid bronchoscope | Age-appropriate (Karl Storz or equivalent) |
| Suction catheter | 8 Fr |
| Complication | Management |
|---|---|
| Laryngospasm | 100% O₂, jaw thrust, propofol 0.5 mg/kg or succinylcholine 1–2 mg/kg |
| Stridor | Nebulised adrenaline (1 mL of 1:1000 in 4 mL saline); dexamethasone 0.25–0.5 mg/kg IV |
| Subglottic oedema | Humidified O₂, adrenaline nebulisation, dexamethasone, ICU observation |
| Bronchospasm | Salbutamol MDI via adaptor, IV aminophylline |
| Residual FB | Repeat bronchoscopy |
| Parameter | Change | Clinical Significance |
|---|---|---|
| pH | ↓ to 6.79 | Metabolic acidosis; however citrate metabolism post-transfusion → alkalosis |
| pCO₂ | ↑ to ~79 mmHg | CO₂ accumulation |
| K⁺ (plasma) | ↑ to ~20 mmol/L by 42 days | Hyperkalaemia risk — neonates, renal failure, rapid/massive transfusion |
| 2,3-DPG | ↓ (depleted by 7–14 days) | Left shift of O₂-Hb dissociation curve → ↑ Hb-O₂ affinity → ↓ O₂ delivery to tissues; regenerates within 24h post-transfusion |
| ATP | ↓ | RBC shape change (echinocytes), ↓ deformability, ↑ haemolysis |
| Lactic acid | ↑ to 9.4 mmol/L | Acidosis |
| Citrate | High concentration | Chelates ionized Ca²⁺ → hypocalcaemia during massive transfusion |
| Microaggregates | ↑ (WBC/platelet debris 20–200 μm) | Pulmonary microvascular obstruction; removed by microfilters |
| Nitric oxide | ↓ | Vasoconstriction, impaired microcirculation |
| Glucose | ↑ initially, ↓ late |
| Clinical Setting | Hb Trigger | Evidence |
|---|---|---|
| General ICU (critically ill) | 7 g/dL (restrictive) | TRICC trial; 2022 Cochrane review (48 RCTs, 21,000 patients) |
| Cardiovascular surgery | 8 g/dL | TRICS-III trial |
| Hip fracture / orthopaedic | 8 g/dL | FOCUS trial |
| Acute MI / ACS | 8 g/dL | MINT trial |
| Massive haemorrhage | Clinical + 1:1:1 protocol | Damage control resuscitation |
| Complication | Frequency | Timing | Mechanism | Management |
|---|---|---|---|---|
| Acute haemolytic | 1:25,000 | Immediate | ABO incompatibility (clerical error) | Stop transfusion; fluids; forced diuresis (mannitol); monitor for DIC; renal protection |
| Delayed haemolytic | 1:12,000 | 2–21 days post | Rh/Kidd/Kell/Duffy alloantibodies | Supportive; crossmatch |
| FNHTR | 1–3% | During/after | Anti-WBC/platelet antibodies | Slow/stop; antipyretics; use leukoreduced blood |
| TRALI | 1:5,000 | Within 6h | HLA antibodies in donor plasma (multiparous females) → neutrophil sequestration in lung | Supportive ventilation (ARDS protocol); usually resolves; use male-only donors for plasma |
| TACO | 1:100 | During/after | Volume/rate overload → cardiogenic pulmonary oedema | Diuretics; slow rate; sitting position |
| Allergic/urticaria | 1% | Immediate | Plasma protein sensitisation | Antihistamines; continue slowly |
| Anaphylaxis | 1:150,000 | Immediate | IgA-deficient patient + anti-IgA | Adrenaline; steroids; antihistamines; use IgA-free products in future |
| GvHD | Rare | 10–30 days | Donor T lymphocytes attack host | Prevention: irradiation (not leukoreduction alone) in immunocompromised |
| TRALI | TACO | |
|---|---|---|
| Mechanism | Non-cardiogenic | Cardiogenic (fluid overload) |
| BNP | Normal/low | ↑ BNP |
| BP | Hypotension | Hypertension |
| PCWP | Normal | ↑ |
| Response to diuretics | No | Yes |
| Onset | Within 6 hours | During/just after |
| Complication | Cause | Management |
|---|---|---|
| Hypocalcaemia | Citrate chelates Ca²⁺ | CaCl₂ 10 mg/kg or calcium gluconate; monitor iCa²⁺ |
| Hyperkalaemia | K⁺ ~20 mEq/L in stored blood | Calcium; slow infusion; wash blood for neonates/renal failure |
| Hypothermia | Cold blood (1–6°C) | Blood warmers (mandatory for massive transfusion) |
| Dilutional coagulopathy | PRBCs without clotting factors | 1:1:1 ratio; cryoprecipitate; TEG-guided |
| Metabolic alkalosis | Citrate → bicarbonate | Self-resolving |
| Pathogen | Risk |
|---|---|
| HIV | 1:1,900,000 |
| HCV | 1:1,900,000 |
| HBV | 1:200,000 |
| Bacterial contamination (platelets highest risk) | 1:2,000–5,000 |
| Gas | Pin Position |
|---|---|
| Oxygen | 2, 5 |
| Nitrous oxide | 3, 5 |
| Air | 1, 5 |
| CO₂ | 1, 6 |
| O₂/CO₂ mixture | 2, 6 |
| Current (AC, 60 Hz) | Effect |
|---|---|
| 1 mA | Threshold of perception |
| 5 mA | Painful sensation |
| 10–20 mA | "Let-go" threshold (sustained muscle contraction, cannot release) |
| 50–100 mA | Respiratory arrest |
| 100 mA (0.1A) | Ventricular fibrillation (macroshock — external) |
| 1–10 A | Sustained VF + burns |
| 180 μA (microamperes) | VF if current applied directly to myocardium (microshock) |
| Macroshock | Microshock | |
|---|---|---|
| Current path | Skin → body → heart → earth | Direct to myocardium (central line, pacing wire) |
| Current for VF | 100 mA | 180 μA (1000× less) |
| Cause | Equipment fault, wet hands | Intracardiac catheter contact with current leak |
| Prevention | Earthing, GFCI, isolated power | Isolated power supply, special "cardiac protected" areas |
| Zone | Examples | Electrical Protection |
|---|---|---|
| Zone 0 (general) | Corridors, waiting areas | Standard earthed supply |
| Zone 1 (Body protected) | Anaesthetic rooms, recovery | GFCI + equipotential bonding |
| Zone 2 (Cardiac protected) | Cardiac catheter labs, ICU with intracardiac devices | Isolated power supply + LIM + microshock protection |
| Class | Earth Connection | Insulation | Examples |
|---|---|---|---|
| Class I | Earthed metal body | Basic | Most OT equipment (anaesthetic machine, monitors) |
| Class II | No earth | Double insulation | Portable equipment, drills |
| Class III | Operates on SELV (<24V DC) | — | Battery-operated devices |
| CF (Cardiac Floating) | No earth; floating input | For cardiac applications | ECG leads on pacemaker patients; intracardiac catheters |
| Parameter | Detail |
|---|---|
| Indication | Sub-umbilical surgeries, inguinal region, perineum |
| Patient position | Left lateral, knee–chest position |
| Landmark | Sacral hiatus (between sacral cornua) → feel "pop" through sacrococcygeal membrane |
| Drug | 0.25% bupivacaine 1 mL/kg (max 20 mL) for sacral block; 0.5 mL/kg for sacral+lumbar |
| Additives | Clonidine 1–2 mcg/kg (prolongs duration to 12h); morphine 30–50 mcg/kg (24h but respiratory depression risk); dexamethasone |
| Duration | Bupivacaine alone ~4–6h; with clonidine ~12h |
| Limitations | Cannot use above umbilicus; limited by volume requirements |
| Parameter | Detail |
|---|---|
| Target | Fascial plane between internal oblique and transversus abdominis — T10–L1 nerves |
| Approach | Subcostal TAP (T8–T10), lateral TAP (T10–L1), posterior TAP (lumbar plexus branches) |
| Probe | High-frequency linear, transverse in mid-axillary line between iliac crest and costal margin |
| Drug | 0.25% bupivacaine 0.5 mL/kg each side (max 2.5 mg/kg total) |
| Duration | 8–12 hours |
| Advantage over caudal | No motor block; bilateral; can be done post-op; suitable above umbilicus |
| Drug | Dose | Notes |
|---|---|---|
| Paracetamol | 15 mg/kg IV/oral q6h (max 60 mg/kg/day) | First-line; safe all ages |
| Ibuprofen | 5–10 mg/kg q6–8h oral (>6 months) | Avoid in <6 months, renal impairment, post-tonsillectomy |
| Morphine | 0.05–0.1 mg/kg IV q3–4h (>6 months) | Titrate; sedation monitoring |
| Fentanyl | 0.5–1 mcg/kg IV (for procedural/breakthrough) | Short-acting |
| Ketamine (subanesthetic) | 0.1–0.3 mg/kg IV bolus | NMDA antagonism; opioid-sparing; reduces central sensitisation |
| Dexmedetomidine | 0.5–1 mcg/kg IV over 10 min | Sedation + analgesia; reduces opioid requirements |
| Parameter | Detail |
|---|---|
| Level | T4–T6 (thoracotomy incision level) |
| Approach | Midline or paramedian; loss of resistance to saline; cephalad catheter placement |
| Drug | 0.1–0.125% bupivacaine + fentanyl 2 mcg/mL infusion at 0.1–0.2 mL/kg/h |
| Duration | Continuous infusion for 48–72 hours |
| Advantages | Excellent analgesia; ↓ pulmonary complications; facilitates early extubation; ↓ opioid requirements |
| Technical difficulty | Small epidural space; ligament flavum less distinct in infants; consider caudal catheter threaded to thoracic level in infants/neonates |
| Parameter | Detail |
|---|---|
| Target | Paravertebral space at T4–T6 level (each level or single injection spreads 3–4 levels) |
| Sonoanatomy | Transverse process, superior costotransverse ligament, paravertebral space (contains intercostal nerve) |
| Drug | 0.25% bupivacaine 0.5 mL/kg per level (OR single injection 0.5–1 mL/kg spread over 3–4 levels); max 2.5 mg/kg |
| Advantage | Unilateral block; lower risk of hypotension vs thoracic epidural; haematoma risk lower; coagulopathy less of contraindication |
| Continuous PVB catheter | 0.1–0.2 mL/kg/h bupivacaine 0.125–0.25% — equivalent to thoracic epidural for post-thoracotomy pain |
| Surgery | First Choice | Alternative | Systemic Adjuncts |
|---|---|---|---|
| Lower abdominal (inguinal, scrotal, perineal) | Caudal block (0.25% bupi 1 mL/kg) | Ilioinguinal/iliohypogastric block | Paracetamol + ibuprofen |
| Lower laparotomy/appendix | TAP block bilateral (0.25% bupi 0.5 mL/kg/side) | Caudal with higher volume | Paracetamol + ketorolac + opioid PRN |
| Thoracotomy | Thoracic epidural (T4–T6, 0.1% bupi + fentanyl) | PVB (0.25% bupi 0.5 mL/kg) | Paracetamol + ketorolac + ketamine infusion |
| Q | One-Liner |
|---|---|
| Q1a | Cardiac arrest in pregnancy: LUD, above-diaphragm IV access, PMCS at 4 min → deliver by 5 min |
| Q1b | Surviving Sepsis Hour-1: Lactate, cultures, antibiotics (1h), 30 mL/kg fluids, norepinephrine if MAP <65 |
| Q2a | AST:ALT >2:1 = alcohol; ALP+GGT ↑ = cholestasis; albumin = chronic synthetic; PT = acute synthetic |
| Q2b | Child-Pugh C (10–15) = 70–80% surgical mortality; atracurium + sevoflurane safe in liver disease |
| Q3a | ACB: in-plane, 15–20 mL lateral to SFA, motor-sparing = earlier ambulation after TKR vs FNB |
| Q3b | RRT: AEIOU indications; CRRT for vasopressor-dependent; citrate anticoagulation preferred; 20–25 mL/kg/h dose |
| Q4 | 1st stage T10–L1 (visceral/C fibres); 2nd stage S2–S4 (somatic/Aδ/pudendal); complete epidural = T10–S4 |
| Q5 | Sitting = 40% VAE; Precordial Doppler + ETCO₂ standard; NO PEEP in VAE; TIVA for IONM; no NMB for CN EMG |
| Q6 | MILS = neutral, no traction, worsens DL → use VL; LeFort II/III = no nasal intubation; CICO = cric |
| Q7 | 2-year-old: ETT 4.5 uncuffed, LMA size 2; inhalational or propofol induction + spontaneous ventilation; no N₂O; nebulised adrenaline + dexamethasone for post-op stridor |
| Q8 | Stored blood: pH↓, K⁺↑ (~20), 2,3-DPG↓ (left shift, regenerates 24h); TRALI within 6h non-cardiogenic; TACO = ↑BNP, responds to diuretics; 1:1:1 + TXA for massive transfusion |
| Q9 | Pin index prevents wrong gas; LIM alarms at 2–5 mA but don't stop surgery; microshock VF at 180 μA (intracardiac) vs 100 mA macroshock; isolated power supply = Zone 2 protection |
| Q10 | Lower abdomen: caudal 0.25% bupi 1 mL/kg; TAP block 0.5 mL/kg/side. Thoracotomy: thoracic epidural T4–T6 gold standard; PVB 0.5 mL/kg equivalent alternative |
Find and Give answer take reference from surviving sepsis guidelines 2026
1. a) Indications of off pump CABG. b) Technique, advantages and disadvantages of off- pump bypass. 2. a) What is preload and after load? b) What are the determinants of left ventricular diastolic function? 3. 4. 5. a) Extracorporeal membrane oxygenation. [2 times] a) Post cardiac arrest care. [5] Discuss the anesthetic considerations and perioperative management of a 75 year male who is a chronic smoker and has a permanent pacemaker in situ posted for transurethral resection of the prostate. 6. 7. 8. 9. b) Non-invasive cardiac output monitoring. b) Use of heparin during cardiopulmonary bypass. Discuss the management of ventricular tachycardia in an adult patient How will you diagnose and manage myocardial ischemia in a patient under general anaesthesia? 10. Discuss the pre, intra and post-operative management of a 53-year-old patient posted for laparoscopic cholecystectomy and detected to be hypertensive in the pre-anaesthetic clinic. [2+6+2] 11. Briefly discuss the preoperative preparation of a 65 year old female patient with coronary artery disease, with a history of drug eluting coronary stenting done one year back, posted for right total knee replacement. [10] 12. b) Cardioplegia. [5] 13. ) Cardioversion. [5] b) Aortocaval compression. 14. Discuss the pre-requisites before starting the weaning from cardiopulmonary bypass 15. Discuss the causes, diagnosis and treatment of atrial fibrillation under anaesthesia. 16. What is blood pressure, how to accurately measure it and enumerate types of hypertension? 17. Draw a labelled diagram and describe in detail the coronary circulation? How can ischemia be monitored during anaesthesia? [3 + 2] b) Discuss the factors that affect myocardial oxygen consumption and the clinical significance 18. A 26-year-old 36 week pregnant female, known case of rheumatic heart disease with severe mitral stenosis, posted for elective LSCS: a) Discuss pathophysiology of mitral stenosis. [5] b) Anesthetic plan of above patient. 19. ) Discuss the pre-anaesthetic evaluation of a 70 year old chronic smoker with systemic hypertension for 10 years on medications, posted for total hip replacement (THR) surgery 20. A 65-year-old patient posted for laparoscopic cholecystectomy, is a known case of ischemic heart disease since last 5 years: a) How will you do risk assessment/stratification of this patient? [5] b) Anesthetic management of above patient. 21. What is the role of TEE in cardiac anaesthesia? 22. a) Describe the pathophysiology of mitral stenosis. [5] b) Discuss the anaesthetic management of a 30-year-old patient with severe mitral stenosis posted for emergency appendicectomy 23. ) ACLS Algorithm for management of ventricular fibrillation. 24. ) Role of ECMO in COVID 25. Inferior venacava collapsibility index 26. Discuss the common complications that can occur after cardiopulmonary bypass surgery and their management. 27. Discuss the indications, contraindications, methods and interpretations of perioperative cardiopulmonary exercise testing. 28. What are the haemodynamic and metabolic changes associated with Aortic Cross Clamping during vascular surgery? What are the therapeutic interventions done to minimise these changes? 29. Enumerate the acyanotic and cyanotic congenital heart malformations in the newborn. [4] b) Discuss the differences between infant and adult cardiopulmonary resuscitation 30. Non invasive cardiac output monitoring. 31. Regulation of Coronary blood flow 32. Describe the factors that may lead to: [4] i) venous air embolism, and ii) arterial air embolism. b) What is paradoxical air embolism, and how does it occur? [3] c) Explain the physiological basis for the use of capnography in the detection of venous air embolism 33. How are implantable cardiac pacemakers and implantable cardioverter defibrillators classified? What information should be sought relating to these devices preoperatively? What precautions should you take perioperatively when anaesthetising patients with these devices? 34. A 65-year-old male patient is posted for total hip replacement. He has a known case of coronary artery disease (CAD) and underwent PTCA one year back, and a drug- eluting stent was placed. He was a known hypertensive and presently receiving oral aspirin, clopidogrel, atenolol and losartan as drug therapy. Discuss the preoperative assessment and anaesthetic plan for this patient. 35. Draw the Algorithm of Comprehensive Cardiopulmonary Life Support (CCLS) guidelines from the Indian Resuscitation Council Federation. Discuss the key parameters for good-quality CPR 36. A 70-year-old frail female is posted for emergency neck femur. She was diagnosed to be diabetic and hypertensive when she had primary coronary stenting for anterior wall myocardial infarction and is on NPH for last 2 years. Her recent transthoracic RS echocardiography showed EF of 50% with diastolic dysfunction. She does not have any other comorbidity. Stratify the cardiac risk, and discuss perioperative cardiac and metabolic concerns briefly including commonly used medications. 37. Temperature management following cardiac arrest from non- shockable rhythm. 38. Enumerate the causes, diagnosis and management of venous air embolism under anaesthesia 39.Elaborate about common complications encountered after CABG(10 mark)
You are a DNB Cardiac Anaesthesia exam expert. Research ALL of the following topics from the medical library database and provide comprehensive, exam-ready answers. Use query_library_db with headings_fts and paragraphs_fts to find relevant sections, then read file content. Cite textbooks (Miller's Anaesthesia, Morgan & Mikhail, Kaplan's Cardiac Anaesthesia, Hensley's Practical Approach to Cardiac Anaesthesia, etc.) QUESTIONS TO ANSWER: **Q1a. Indications of Off-Pump CABG (OPCAB)** **Q1b. Technique, advantages and disadvantages of off-pump bypass** **Q2a. What is preload and afterload?** **Q2b. Determinants of left ventricular diastolic function** **Q3/Q5a. Extracorporeal Membrane Oxygenation (ECMO)** — types (VA/VV), indications, circuit components, anticoagulation, weaning, complications **Q4. Post Cardiac Arrest Care** — targeted temperature management, coronary angiography, haemodynamic targets, neuroprognostication, avoid hyperoxia/hyperthermia **Q5. Anaesthetic management of 75-year-old chronic smoker with permanent pacemaker posted for TURP** — pacemaker precautions, diathermy, spinal vs GA, TURP syndrome, fluid management **Q6b. Non-invasive cardiac output monitoring** — pulse contour, thoracic bioimpedance, bioreactance, oesophageal Doppler, USCOM, NICO, plethysmography **Q7b. Use of heparin during cardiopulmonary bypass** — dosing (300-400 IU/kg), ACT targets (>480 seconds), protamine reversal, HIT, heparin resistance **Q8. Management of ventricular tachycardia in adult** — stable vs unstable VT, amiodarone, lidocaine, cardioversion, ACLS algorithm, causes (ACLS reversible causes) **Q9. Diagnosis and management of myocardial ischemia under general anaesthesia** — ECG changes (ST depression/elevation), TEE (RWMA), haemodynamic signs, treatment (nitroglycerin, beta-blockers, correct haemodynamics) **Q10. Pre, intra and post-operative management of 53-year-old posted for laparoscopic cholecystectomy with hypertension found in pre-anaesthetic clinic** — [2+6+2 marks]: pre-op BP control, antihypertensive continuation, intraoperative haemodynamic management, pneumoperitoneum effects, post-op analgesia **Q11. Preoperative preparation of 65-year-old female with CAD and drug-eluting stent (1 year back) posted for total knee replacement** — antiplatelet therapy (DAPT — when to stop clopidogrel, continue aspirin), perioperative cardiac risk, bridging, premedication, monitoring **Q12b. Cardioplegia** — types (crystalloid vs blood), composition (K+, Mg, buffer), antegrade vs retrograde, warm vs cold, St Thomas solution, del Nido, mechanism of arrest **Q13a. Cardioversion** — elective vs emergency, energy levels, synchronisation, anticoagulation, complications **Q13b. Aortocaval compression** — mechanism, Birnbach position, maternal resuscitation, PMCS SEARCH INSTRUCTIONS: - SQL example: SELECT title, book_title, '/textbooks/' || block_file_path AS file_path, line_number, para_line_ranges FROM headings_fts WHERE headings_fts MATCH 'off pump coronary bypass' ORDER BY rank LIMIT 5 - Read file content after getting paths - Provide detailed, structured answers with tables, drug doses, clinical algorithms - All answers should be exam-ready for DNB Cardiac Anaesthesia post-diploma paper Return comprehensive answers for ALL questions above.
You are a DNB Cardiac Anaesthesia exam expert. Research ALL of the following topics from the medical library database and provide comprehensive, exam-ready answers. Use query_library_db with headings_fts and paragraphs_fts to find relevant sections, then read file content. Cite textbooks (Miller's Anaesthesia, Morgan & Mikhail, Kaplan's Cardiac Anaesthesia, Hensley's Practical Approach to Cardiac Anaesthesia, etc.) QUESTIONS TO ANSWER: **Q14. Prerequisites before starting weaning from cardiopulmonary bypass (CPB)** - Temperature (>37°C core), rhythm (sinus), haematocrit (>25%), electrolytes (K+, Ca2+, Mg2+), acid-base, ventilation restarted, surgical haemostasis, de-airing, vasopressors ready, monitoring (TEE, arterial line, CVP), inotropes if needed **Q15. Causes, diagnosis and treatment of atrial fibrillation under anaesthesia** - Causes: surgical manipulation, ischaemia, electrolyte disturbance, hypoxia, post-CPB - Rate vs rhythm control, amiodarone, beta-blockers, cardioversion, anticoagulation **Q16. What is blood pressure, how to accurately measure it, and types of hypertension** - Definition, Korotkoff sounds, cuff size requirements, ABPM, invasive arterial, white coat, masked, essential vs secondary hypertension classification **Q17. Labelled diagram and description of coronary circulation + ischemia monitoring during anaesthesia + factors affecting myocardial O2 consumption** - RCA/LCA anatomy, dominance, autoregulation, coronary perfusion pressure - Ischemia monitoring: 12-lead ECG, ST analysis, TEE (RWMA most sensitive), PA catheter - MVO2 determinants: heart rate (most important), wall tension (preload/afterload), contractility **Q18a. Pathophysiology of mitral stenosis** - Rheumatic fever, valve area (<1 cm2 severe), pressure gradient, LAP ↑, LA dilatation, AF, pulmonary hypertension, RV failure, low CO **Q18b. Anaesthetic plan for severe MS with 36-week pregnancy for LSCS** - Avoid tachycardia, maintain preload but avoid fluid overload, avoid aortocaval compression, regional (spinal with caution vs slow epidural), GA if necessary, vasopressor choice (phenylephrine), oxytocin cautiously **Q19. Pre-anaesthetic evaluation of 70-year-old chronic smoker with systemic hypertension for THR** - Cardiovascular (RCRI, functional capacity, ECG, echo if EF concern), pulmonary (PFTs, CXR, optimization), antihypertensive medication, DVT risk, anaemia correction, smoking cessation **Q20a. Risk assessment/stratification of 65-year-old with IHD for laparoscopic cholecystectomy** - ACC/AHA stepwise algorithm: emergency? → active cardiac conditions? → low risk surgery? → functional capacity ≥4 METs? → clinical risk factors (RCRI) - Lee's Revised Cardiac Risk Index (RCRI) — 6 factors, score interpretation **Q20b. Anaesthetic management of above patient** **Q21. Role of TEE in cardiac anaesthesia** - Indications (haemodynamic instability, valve surgery, aortic surgery), ASE/SCA views, what TEE can show (RWMA, EF, valvular function, air, clot, aorta), limitations **Q22a. Pathophysiology of mitral stenosis** (same as Q18a — cover completely) **Q22b. Anaesthetic management of 30-year-old with severe MS for emergency appendicectomy** - Emergency: cannot delay; RSI with ketamine caution vs etomidate; maintain HR <80; avoid tachycardia; epidural if coagulation normal; fluid cautious; vasopressors **Q23. ACLS Algorithm for VF management** - Shockable rhythm algorithm: CPR 2 min → shock 200J biphasic → CPR → epinephrine 1mg q3-5min → amiodarone 300mg → shock → CPR cycles; reversible causes 4H4T **Q24. Role of ECMO in COVID** - VVECMO for refractory ARDS (P:F <80 despite prone), ELSO criteria, outcomes **Q25. IVC Collapsibility Index** - IVC diameter measurement (M-mode), calculation: (IVCmax-IVCmin)/IVCmax × 100 - >50% = fluid responsive; <50% = not responsive; limitations (spontaneous breathing, RV failure, intraabdominal hypertension) **Q26. Common complications after CPB and their management** - Neurological (stroke, cognitive dysfunction), cardiac (LCO, arrhythmias, myocardial stunning), pulmonary (ARDS, pleural effusion), renal (AKI), haematological (coagulopathy, HIT), gastrointestinal (mesenteric ischaemia), systemic inflammatory response **Q27. Indications, contraindications, methods and interpretations of perioperative CPET** - VO2max, AT (anaerobic threshold), VE/VCO2 slope, AT <11 mL/kg/min = high risk, AT >11 = moderate, VO2 peak <15 mL/kg/min = high risk; 6-minute walk test alternative **Q28. Haemodynamic and metabolic changes with aortic cross-clamping + therapeutic interventions** - Infrarenal clamping vs supraceliac: ↑ SVR, ↑ afterload, ↑ MAP, ↓ distal blood flow; declamping: ↓ SVR, ↓ MAP, metabolic acidosis (reperfusion), myocardial depression - Interventions: vasodilators (nitroprusside, GTN), volume loading, inotropes, mannitol for kidneys, hypothermia **Q29a. Acyanotic and cyanotic congenital heart malformations** - Acyanotic: VSD, ASD, PDA, coarctation, pulmonary stenosis, aortic stenosis - Cyanotic: TOF, TGA, tricuspid atresia, truncus arteriosus, TAPVD, Ebstein anomaly **Q29b. Differences between infant and adult CPR** **Q33. Classification of pacemakers and ICDs + preoperative information + perioperative precautions** - NBG/NASPE-BPEG code (5-letter): 1st=chamber paced, 2nd=sensed, 3rd=response, 4th=rate modulation, 5th=multisite pacing - ICD classification (HRS/NASPE) - Preop info: indication, generator type, dependency, last interrogation, battery status - Periop: bipolar diathermy preferred, magnet application (converts to asynchronous DOO/VOO), CIED team involvement, deactivate ICD shock function **Q34. Preoperative assessment and anaesthetic plan for 65-year-old CAD patient with DES (1 year back), hypertensive on aspirin+clopidogrel+atenolol+losartan for THR** - Same as Q11 but more detailed: DAPT management (DES <12 months = very high risk; 1 year = continue aspirin, can stop clopidogrel 5-7 days before if bleeding risk high), ACC/AHA guidelines, bridging (NOT with UFH for stent patients), neuraxial anaesthesia timing (wait 7 days after clopidogrel stop), continue atenolol perioperatively, ACE-i/ARB (losartan) — hold on morning of surgery for non-cardiac surgery **Q35. CCLS algorithm from Indian Resuscitation Council + key parameters for good CPR** - Based on AHA 2020/BLS: compressions 100-120/min, depth 5-6 cm, full chest recoil, minimize interruptions, compression fraction >60%, capnography feedback **Q36. 70-year-old frail female for emergency neck femur — diabetic+hypertensive+coronary stenting for AWMI+NPH insulin+EF 50% with diastolic dysfunction — stratify cardiac risk + perioperative concerns** - Emergency surgery: Revised Lee's RCRI scoring, ACS risk, insulin management perioperatively (glucose 6-10 mmol/L target), diastolic dysfunction implications (avoid tachycardia, maintain sinus rhythm, adequate preload), statin continuation, beta-blocker continuation, neuraxial preference **Q37. Temperature management following cardiac arrest from non-shockable rhythm (PEA/Asystole)** - AHA 2023 update: Targeted Temperature Management (TTM) — avoid fever (>37.5°C) mandatory; TTM at 32-36°C for 24h — evidence evolving (TTM2 trial: no benefit of 33°C vs normothermia in unwitnessed arrest); fever avoidance universally recommended; ILCOR 2021 **Q38. Causes, diagnosis and management of venous air embolism under anaesthesia** - Causes: sitting position, open veins above heart level, Trendelenburg, laparoscopy (CO2), central line placement - Diagnosis: ETCO2 sudden drop, precordial Doppler (most sensitive), mill-wheel murmur, TEE - Management: Stop N2O, 100% O2, flood surgical field, left lateral decubitus + Trendelenburg (Durant manoeuvre), aspirate CVP catheter, CPR if arrest **Q39. Common complications after CABG (10 marks)** - Cardiovascular: low cardiac output syndrome (IABP, inotropes), arrhythmias (AF 20-40%, amiodarone), myocardial infarction, tamponade - Neurological: stroke (1-3%), cognitive dysfunction, peripheral neuropathy - Pulmonary: atelectasis, pleural effusion, ARDS, phrenic nerve palsy - Renal: AKI (post-CPB inflammatory response, contrast, low CO) - Haematological: coagulopathy, HIT - Sternal wound: mediastinitis, dehiscence - Vascular graft: early graft failure, graft spasm SEARCH INSTRUCTIONS: - SQL: SELECT title, book_title, '/textbooks/' || block_file_path AS file_path, line_number, para_line_ranges FROM headings_fts WHERE headings_fts MATCH 'cardiopulmonary bypass weaning' ORDER BY rank LIMIT 5 - Also: SELECT book_title, section_heading, '/textbooks/' || block_file_path AS file_path, line_start, line_end, snippet(paragraphs_fts, 0, '>>>', '<<<', '...', 30) as snippet FROM paragraphs_fts WHERE paragraphs_fts MATCH 'ventricular tachycardia amiodarone' ORDER BY rank LIMIT 5 - Read file content after getting paths using read_file - Cite specific textbooks (Miller's, Kaplan's, Morgan & Mikhail, Hensley's, Hines) - Provide detailed, structured exam answers with tables, drug doses, algorithms Return comprehensive answers for ALL questions listed above.
1. CABG + Cardiopulmonary Bypass (CPB) CABG * Off-pump CABG (OPCAB) * Indications * Technique * Advantages & disadvantages * Common complications after CABG and management Cardiopulmonary Bypass * Heparin use during CPB * Cardioplegia * Weaning from CPB — prerequisites * Complications after CPB and management * Aortic cross-clamping * Hemodynamic changes * Metabolic changes * Therapeutic interventions ⸻ 2. ECMO * Extracorporeal membrane oxygenation (ECMO) * Role of ECMO in COVID ⸻ 3. Cardiac Arrest, CPR & Post-Resuscitation Care Cardiac Arrest Care * Post-cardiac arrest care * Temperature management after cardiac arrest (non-shockable rhythm) CPR * ACLS algorithm for ventricular fibrillation * Comprehensive Cardiopulmonary Life Support (CCLS) guidelines * Parameters of good-quality CPR * Differences between infant and adult CPR ⸻ 4. Arrhythmias & Electrical Therapy Ventricular Tachycardia / Ventricular Fibrillation * Management of ventricular tachycardia * ACLS for VF Atrial Fibrillation * Causes * Diagnosis * Treatment under anaesthesia Cardioversion * Indications * Technique * Precautions * Complications ⸻ 5. Pacemakers, ICD & Cardiac Devices * Classification of pacemakers and ICDs * Preoperative evaluation * Perioperative precautions * Anaesthetic considerations in patients with permanent pacemaker ⸻ 6. Myocardial Ischemia, Coronary Circulation & CAD Myocardial Ischemia * Diagnosis of myocardial ischemia under GA * Management under anaesthesia * Monitoring of ischemia during anaesthesia Coronary Circulation * Coronary circulation (diagram + description) * Regulation of coronary blood flow Myocardial Oxygen Balance * Factors affecting myocardial oxygen consumption * Clinical significance CAD Patients for Non-cardiac Surgery * CAD with drug-eluting stent for non-cardiac surgery * Preoperative assessment * Risk stratification * Anaesthetic plan Common surgeries asked: * Total knee replacement * Total hip replacement * Laparoscopic cholecystectomy ⸻ 7. Hypertension & Blood Pressure * Definition of blood pressure * Accurate BP measurement * Types of hypertension * Perioperative management of hypertensive patient ⸻ 8. Valvular Heart Disease — Mitral Stenosis Pathophysiology * Mitral stenosis pathophysiology Anaesthetic Management * Severe MS for: * LSCS * Emergency appendicectomy ⸻ 9. Cardiac Risk Assessment & Preoperative Evaluation High-risk/Frail Patients * Elderly smoker with hypertension * Frail elderly with CAD/diabetes * Diastolic dysfunction Topics commonly integrated * Functional capacity * Risk indices * Optimization * Medication management * Perioperative cardiac concerns * Metabolic concerns ⸻ 10. Cardiac Output Monitoring * Non-invasive cardiac output monitoring ⸻ 11. Ventricular Function & Hemodynamics Basic Hemodynamics * Preload * Afterload LV Diastolic Function * Determinants of LV diastolic function ⸻ 12. Transesophageal Echocardiography (TEE) * Role of TEE in cardiac anaesthesia ⸻ 13. Cardiopulmonary Exercise Testing (CPET) * Indications * Contraindications * Methods * Interpretation ⸻ 14. Venous Air Embolism (VAE) Causes * Venous air embolism * Arterial air embolism Pathophysiology * Paradoxical air embolism Diagnosis * Role of capnography Management * Treatment under anaesthesia ⸻ 15. Obstetric Cardiac Anaesthesia * Aortocaval compression * Severe mitral stenosis in pregnancy/LSCS ⸻ 16. Congenital Heart Disease * Cyanotic congenital heart disease * Acyanotic congenital heart disease ⸻ 17. IVC Ultrasound * Inferior vena cava collapsibility index Answer these question for dnb theory exam anaesthesia consise of possible pneumonic to learn and under subheadings from genuine source like miller stoeilting and latest guidelines if any
You are a DNB Anaesthesia exam expert specializing in cardiac anaesthesia. Research the following topics from the medical library database. Use query_library_db with headings_fts and paragraphs_fts searches, then read file content with read_file. Cite Miller's Anaesthesia, Kaplan's Cardiac Anaesthesia, Morgan & Mikhail, Hensley's Practical Approach to Cardiac Anaesthesia. TOPICS TO COVER (Part 1 — CABG, CPB, ECMO, Cardiac Arrest, Arrhythmias): **SECTION 1: CABG & CARDIOPULMONARY BYPASS** 1. **Off-pump CABG (OPCAB)** - Indications (high-risk patients: elderly, renal failure, calcified aorta, prior stroke, severe atherosclerosis) - Technique: stabilizers (Octopus tissue stabilizer), MIDCAB, positioning, shunts, conversion to on-pump - Advantages: avoids CPB-related inflammation, no aortic manipulation, less cognitive dysfunction, less blood transfusion, faster recovery - Disadvantages: technically demanding, incomplete revascularization, haemodynamic instability during vessel exposure, graft quality concerns 2. **Common complications after CABG and management** - Cardiovascular: Low cardiac output syndrome (LCOS), arrhythmias (AF 20-40%), perioperative MI, tamponade - Neurological: stroke (1-3%), neurocognitive dysfunction - Pulmonary: atelectasis, ARDS, phrenic nerve palsy, pleural effusion - Renal: AKI - Haematological: coagulopathy, HIT - Sternal: mediastinitis, wound dehiscence - Graft failure 3. **Heparin use during CPB** - Dose: 300-400 IU/kg to achieve ACT >480 seconds (some centres >400 sec) - ACT monitoring (Hemochron/HemoTec) - Supplemental dosing during long bypass - Protamine reversal: 1 mg per 100 IU heparin given; protamine reactions (anaphylaxis, pulmonary hypertension) - Heparin resistance (AT-III deficiency — give FFP or AT-III concentrate) - HIT (Type I vs Type II) — bivalirudin alternative 4. **Cardioplegia** - Definition and mechanism: arrest in diastole, reduce O2 consumption - Types: crystalloid (St Thomas' solution) vs blood cardioplegia (4:1 blood:crystalloid) - Composition: high K+ (20-40 mEq/L arrests heart), Mg2+, procaine, bicarbonate buffer - Temperature: cold (4°C) vs warm (37°C) vs tepid (29°C) - Route: antegrade (aortic root/coronary ostia) vs retrograde (coronary sinus) - del Nido cardioplegia (paediatric and adult use) - Modern blood cardioplegia advantages over crystalloid - Myocardial protection: ischaemic preconditioning, postconditioning 5. **Weaning from CPB — prerequisites** (mnemonic: RSVP-WAVE or similar) - Temperature: core ≥37°C, bladder/rectal ≥35°C - Rhythm: sinus or adequate paced rhythm - Ventilation: lungs re-inflated, FiO2 1.0, ETCO2 present - Rate: HR 80-100 bpm - Volume: adequate filling (check TEE) - Arterial: MAP 60-80 mmHg - Wires: pacing wires functional - Electrolytes: K+ 4-5 mEq/L, Ca2+ normalized, Hct >25% - Surgical: haemostasis, de-airing (TEE), grafts checked - Drugs: inotropes/vasopressors ready; reverse heparin timing 6. **Complications after CPB and management** - Systemic inflammatory response (SIRS) — complement activation, cytokines - Cognitive dysfunction (pump head) - Coagulopathy: heparin rebound, platelet dysfunction, fibrinolysis — FFP, platelets, cryoprecipitate, TXA - Vasoplegic syndrome (profound vasodilatation post-CPB) — vasopressin, methylene blue, norepinephrine - Pulmonary: post-CPB lung injury - Renal: AKI — KDIGO criteria, RRT - Haemodilution anaemia 7. **Aortic cross-clamping — haemodynamic and metabolic changes + interventions** - CLAMPING: ↑ SVR, ↑ MAP, ↑ afterload, ↑ cardiac work, proximal hypertension; distal ischaemia (spinal cord, kidneys, mesenteric) - Infrarenal vs suprarenal vs supraceliac differences - UNCLAMPING (declamping): ↓ SVR, ↓ MAP (declamping hypotension), metabolic acidosis (reperfusion), myocardial depression from humoral factors, reactive hyperaemia - Metabolic: ischaemia-reperfusion injury, lactic acid, reactive oxygen species - Interventions: * During clamping: vasodilators (SNP, GTN), volume loading * Before unclamping: volume pre-loading, vasopressors ready, correct acidosis (bicarbonate) * Organ protection: mannitol, steroids, hypothermia (spinal cord cooling) * Spinal cord protection: CSF drainage, SSEP/MEP monitoring, permissive hypertension **SECTION 2: ECMO** 8. **Extracorporeal Membrane Oxygenation (ECMO)** - Principles: prolonged cardiac/pulmonary support - Types: VV-ECMO (respiratory support) vs VA-ECMO (cardiac + respiratory support) - Circuit components: cannulae, pump (centrifugal), membrane oxygenator, heat exchanger, monitoring - VV-ECMO: cannulation (femoral vein → internal jugular), flow 4-6 L/min, indications (ARDS, P:F <80 despite optimal ventilation, prone positioning) - VA-ECMO: peripheral (femoral artery + vein) vs central; indications (cardiogenic shock, post-cardiotomy failure, bridge to transplant/recovery, refractory cardiac arrest — ECPR) - Anticoagulation: UFH infusion, target aPTT 60-80 sec or ACT 180-220 sec - Weaning VV: FiO2 sweep gas ↓; weaning VA: flow ↓ gradually - Complications: bleeding (cannula site, intracranial), thromboembolism, limb ischaemia (distal perfusion catheter), infection, haemolysis, Harlequin syndrome (VA), air embolism - ELSO guidelines 9. **Role of ECMO in COVID** - VV-ECMO for COVID-ARDS: when P:F ratio <80 despite proning, neuromuscular blockade, optimal PEEP - ELSO/WHO criteria - COVID-specific issues: coagulopathy (thrombosis risk on ECMO), myocarditis (VA-ECMO) - Outcomes: ELSO registry data - Resource allocation challenges **SECTION 3: CARDIAC ARREST, CPR, POST-RESUSCITATION CARE** 10. **Post-cardiac arrest care (PCAC)** - Immediate: secure airway (intubate if not done), mechanical ventilation (SpO2 94-98%, PaCO2 35-45 mmHg), avoid hyperoxia and hyperventilation - Haemodynamic: MAP ≥65 mmHg, SBP >90 mmHg; norepinephrine/vasopressin for vasopressor support; consider early coronary angiography (STEMI → immediate cath lab) - Targeted Temperature Management (TTM): 32-36°C for 24 hours (if comatose post-ROSC) — AHA 2020; TTM2 trial (2021) showed no benefit of 33°C over 37.5°C (fever avoidance); current: prevent fever >37.7°C mandatory - Neuroprognostication: ≥72 hours after arrest; SSEP (bilateral absent N20), EEG, CT brain, neuron-specific enolase (NSE), clinical exam (pupillary reflex, motor response) - Glucose: target 7.8-10 mmol/L (avoid hypoglycaemia) 11. **Temperature management after cardiac arrest from non-shockable rhythm (PEA/Asystole)** - TTM2 trial 2021: 1861 patients; no mortality benefit of 33°C vs normothermia (fever avoidance <37.8°C) - ILCOR/AHA 2021 update: for non-shockable rhythms — evidence less clear; FEVER AVOIDANCE (T <37.7°C) recommended universally - For shockable rhythms (VF/pVT): TTM at 32-36°C for 24h still recommended (weak evidence, 2023 ILCOR update) - Practical implementation: cooling blankets, ice packs, intravascular cooling catheters - Rewarming: 0.25°C/hour, avoid fever for 72h post-arrest 12. **ACLS Algorithm for Ventricular Fibrillation** - Unresponsive + no normal breathing → activate emergency response + CPR - Shockable rhythm (VF/pulseless VT): * Shock 200J biphasic → immediate CPR 2 min → rhythm check * If still shockable: Shock → CPR 2 min → Epinephrine 1mg IV every 3-5 min * If still shockable: Shock → CPR 2 min → Amiodarone 300mg IV (or lidocaine 1-1.5 mg/kg) * Continue cycles; second amiodarone 150mg - Reversible causes: 4Hs (Hypoxia, Hypovolaemia, Hypo/Hyperkalaemia, Hypothermia) and 4Ts (Tension pneumothorax, Tamponade, Toxins/Thrombosis-PE, Thrombosis-coronary) - Post-ROSC care 13. **CCLS (Comprehensive Cardiopulmonary Life Support) from Indian Resuscitation Council** - IRC (Indian Resuscitation Council) guidelines align with AHA/ERC 2020 - Basic Life Support → Advanced Life Support → Post-resuscitation care chain - Community CPR emphasis in Indian context - CCLS mnemonic: similar to ACLS but with Indian healthcare system adaptations 14. **Parameters of good-quality CPR** - Rate: 100-120 compressions/minute - Depth: 5-6 cm (adults); 4 cm infants, 5 cm children - Full chest recoil between compressions - Minimize interruptions (pre-shock pause <10 sec) - Compression fraction >60% (ideally >80%) - Avoid hyperventilation: 10 breaths/min after intubation - Use of feedback devices (metronome, mechanical CPR) - Capnography: ETCO2 <10 mmHg suggests poor CPR quality; ETCO2 >40 mmHg = ROSC 15. **Differences between infant and adult CPR** - Cause: respiratory in children vs cardiac in adults - Compressions: 2 thumbs (infant <1yr), 2 fingers, heel of one hand (child), 2 hands (adult) - Depth: 4 cm (infant), 5 cm (child), 5-6 cm (adult) - Ratio: 15:2 for 2-rescuer paediatric; 30:2 adult - Defibrillation: 4 J/kg paediatric (2J/kg initial); 200J adult - Airway: head-tilt/chin-lift; neutral position (infant), sniffing position (child) - Drug doses: weight-based (adrenaline 0.01 mg/kg) - Vascular access: IO if IV fails (tibial tuberosity in child) **SECTION 4: ARRHYTHMIAS** 16. **Management of Ventricular Tachycardia** - Haemodynamically UNSTABLE VT (no pulse or pulseless): treat as VF — immediate defibrillation - Haemodynamically STABLE VT (pulse present): * Regular, monomorphic: Amiodarone 150mg IV over 10 min; or lidocaine 1-1.5 mg/kg; or Procainamide * Polymorphic VT (normal QT): treat ischaemia; amiodarone * Torsades de Pointes (↑QT): Magnesium sulphate 2g IV; overdrive pacing; stop offending drug * If drugs fail: synchronized cardioversion (100J monophasic, 50-100J biphasic) - Causes: ACLS 4H4T; ischaemia (most common perioperative) - Perioperative: correct electrolytes (K+ >4, Mg2+ >1), treat ischaemia, avoid triggering agents 17. **Atrial Fibrillation under anaesthesia — Causes, Diagnosis, Treatment** - Causes: NEW AF under anaesthesia: hypoxia, hypercarbia, electrolyte disturbance (K+, Mg2+), ischaemia, surgical manipulation (cardiac surgery, pneumonectomy), pain, catecholamines, hypovolaemia, full bladder - Post-CPB AF: most common arrhythmia (25-40%), peak 2-3 days post-op, amiodarone prophylaxis reduces incidence - Diagnosis: irregular rhythm, absent P waves, variable RR interval on ECG - Treatment: * Haemodynamically unstable: immediate synchronized DC cardioversion (200J) * Stable with rapid ventricular rate: rate control: beta-blocker (metoprolol 5mg IV), diltiazem, digoxin; amiodarone (150mg IV) * Rhythm control: amiodarone 5-7 mg/kg IV over 30-60 min * Anticoagulation if >48h duration (LMWH, heparin bridge) * Correct underlying cause 18. **Cardioversion** - Elective DC cardioversion: for AF, flutter, SVT, stable VT - Energy: AF 100-200J biphasic (120-200J); SVT/flutter: 50-100J; VT (stable): 100J - SYNCHRONISATION: essential for all except VF (synchronise to R wave to avoid delivery on T wave → VF) - Preoperative: anticoagulate ≥3 weeks if AF >48h OR TOE to exclude LA thrombus; NOAC/warfarin (INR 2-3) - Sedation/anaesthesia: propofol 1-2 mg/kg or midazolam; monitor SpO2, NIBP, ECG - Post-cardioversion: continue anticoagulation ≥4 weeks (stunning); monitor rhythm - Complications: skin burns, thromboembolism, arrhythmias (post-shock bradycardia), pulmonary oedema, failed cardioversion SEARCH INSTRUCTIONS: - Use: SELECT title, book_title, '/textbooks/' || block_file_path AS file_path, line_number, para_line_ranges FROM headings_fts WHERE headings_fts MATCH 'cardiopulmonary bypass heparin' ORDER BY rank LIMIT 5 - Read actual file content - Provide clear subheadings, tables, mnemonics where possible - Include drug doses throughout Return comprehensive, well-structured answers for ALL topics above suitable for DNB theory exam.
You are a DNB Anaesthesia exam expert specializing in cardiac anaesthesia. Research the following topics from the medical library database. Use query_library_db with headings_fts and paragraphs_fts searches, then read file content with read_file. Cite Miller's Anaesthesia, Kaplan's Cardiac Anaesthesia, Morgan & Mikhail, Hensley's Practical Approach to Cardiac Anaesthesia, Stoelting's. TOPICS TO COVER (Part 2 — Pacemakers, Ischemia, Coronary Circulation, Hypertension, Valvular Disease, Risk Assessment, Non-invasive CO, TEE, CPET, Air Embolism, Obstetric, Congenital, IVC): **SECTION 5: PACEMAKERS AND ICDs** 1. **Classification of pacemakers and ICDs** - NBG/NASPE-BPEG 5-letter code: * Position I: Chamber paced (O=none, A=atrium, V=ventricle, D=dual) * Position II: Chamber sensed (O, A, V, D) * Position III: Response to sensing (O=none, I=inhibited, T=triggered, D=dual) * Position IV: Rate modulation (O=none, R=rate responsive) * Position V: Multisite pacing (O, A, V, D) - Common modes: VVI (pacemaker-dependent), DDD (physiological), VOO (asynchronous), AOO - ICD classification: HRS code — shock coil position, detection/therapy zones - CIED (Cardiac Implantable Electronic Device) terminology 2. **Preoperative evaluation of pacemaker/ICD patient** - KNOW: Why device implanted (indication — complete heart block, SSS, CHF resynchronisation) - Device details: manufacturer, model, year implanted, last interrogation date - Battery status (elective replacement indicator) - Pacemaker dependency: is patient pacemaker-dependent? (rate <40 without pacing) - Current settings: base rate, upper rate, pacing thresholds, sensing - ICD: is anti-tachycardia therapy (shock) active? When last shocked? - CXR: verify lead positions - Functional assessment: recent ECG showing capture 3. **Perioperative precautions and anaesthetic considerations for permanent pacemaker/ICD** - ELECTROSURGERY (diathermy): greatest risk — EMI can inhibit pacing or trigger ICD shock * BIPOLAR diathermy: preferred (minimal EMI); current stays between forcep tips * MONOPOLAR: use only if unavoidable; short bursts; keep return plate far from device; keep current path away from CIED * Keep monopolar current path >15 cm from pacemaker - MAGNET application: * Pacemaker: converts to asynchronous (AOO/VOO/DOO) at manufacturer-specific magnet rate — protects pacemaker-dependent patient from inhibition by EMI * ICD: SUSPENDS anti-tachycardia therapy (shocks) — DOES NOT change pacing mode * Should have external defibrillator immediately available if ICD inactivated - REPROGRAMMING: preferred for high-EMI procedures (laparoscopy, TURP); reprogram to VOO/AOO and disable ICD therapies via programmer; restore post-op - Monitoring: continuous ECG, pulse oximetry (verify mechanical pulse with each pacemaker spike) - Positioning: avoid stretching arm above head (can displace leads) - Avoid: succinylcholine fasciculations (may cause EMI-like signals); neostigmine (bradycardia in non-dependent patients) - MRI: MRI-conditional devices require specific protocols **SECTION 6: MYOCARDIAL ISCHEMIA, CORONARY CIRCULATION** 4. **Diagnosis and management of myocardial ischemia under GA** - DIAGNOSIS: * ECG: most practical — new ST depression >1mm (horizontal/downsloping), ST elevation (STEMI), new T-wave inversion, new LBBB; Monitor leads II (inferior) + V5 (anterior = most sensitive lead) * TEE: new RWMA (Regional Wall Motion Abnormality) — most sensitive (precedes ECG changes); appears before ST changes; wall motion score * PA catheter: new V wave on PCWP trace (MR from ischaemia), ↑ PCWP, ↓ CO * Clinical: new hypotension, tachycardia, ↑ CVP - MANAGEMENT (mnemonic: ABCDE or "FIX IT"): * Fix the rate: HR 60-80 bpm; beta-blocker (esmolol 0.5 mg/kg) or increase depth of anaesthesia * Fix preload: correct hypovolaemia (restore coronary perfusion pressure = DBP - LVEDP) * Fix afterload: if hypertensive → nitroglycerin (GTN) 0.5-5 mcg/kg/min (↓ preload, dilates coronaries) * Fix coronary perfusion: ensure DBP adequate (phenylephrine if DBP low) * Oxygen: increase FiO2; correct anaemia if Hb <8 * Consider: IABP if haemodynamically compromised; heparin; post-op cath lab * Notify surgeon: consider whether to proceed or abort 5. **Coronary circulation — diagram + description + regulation** - ANATOMY: * LCA (Left Coronary Artery): arises from left coronary sinus of Valsalva - LAD (Left Anterior Descending): supplies anterior LV wall, anterior septum, apex; diagonal branches - LCx (Left Circumflex): supplies lateral LV wall, posterior LV (left dominant); obtuse marginal branches * RCA (Right Coronary Artery): arises from right coronary sinus; supplies right ventricle, inferior LV (right dominant), SA node (55%), AV node (90%) - DOMINANCE: Right dominant (85%) = RCA gives PDA; Left dominant (10%); Co-dominant (5%) - PERFUSION TIMING: LV perfuses during DIASTOLE (systole compresses intramyocardial vessels); RV perfuses during both systole and diastole - CORONARY PERFUSION PRESSURE (CPP) = DBP − LVEDP (target DBP >60 mmHg perioperatively) - REGULATION: Autoregulation maintains CBF constant at MAP 60-160 mmHg * Metabolic: adenosine (most important vasodilator), CO2, O2, K+, H+ * Myogenic: pressure-flow autoregulation * Neurogenic: alpha-adrenergic (vasoconstriction), beta-2 (vasodilation) * Endothelial: NO (vasodilation), endothelin (vasoconstriction) - In anaemia/hypotension: autoregulation fails → supply-demand mismatch 6. **Factors affecting myocardial O2 consumption (MVO2)** - DETERMINANTS (mnemonic: THRC = Three HR Components): * HEART RATE: MOST IMPORTANT determinant (doubles MVO2 when HR doubles); also reduces diastolic filling time → ↓ perfusion * WALL TENSION (Laplace's law = P×r/2h): determined by PRELOAD (EDV) + AFTERLOAD (SVR) * CONTRACTILITY (inotropy): ↑ contractility → ↑ MVO2 * Basal metabolism (~20% MVO2): irreducible minimum for cell viability - O2 SUPPLY factors: coronary flow, Hb, SpO2, CPP - SUPPLY:DEMAND RATIO determines ischaemia - Clinical significance: * Tachycardia: most dangerous (↑ demand + ↓ supply) → beta-blockers * Hypertension: ↑ afterload → ↑ MVO2 → treat perioperative hypertension * Anaemia: ↓ supply → transfuse if Hb <8 in CAD * Nitrates: ↓ preload + coronary dilation → reduce MVO2 7. **CAD with drug-eluting stent — preoperative assessment + anaesthetic plan** - ANTIPLATELET THERAPY (DAPT): * BMS (bare metal stent): defer elective surgery ≥4-6 weeks minimum; ideally 3 months * DES (drug-eluting stent): defer elective surgery ≥6 months (old DES) to ≥12 months ideally; ≥3 months if surgery cannot be delayed (ACC/AHA 2022 guidelines) * If surgery urgent: CONTINUE BOTH aspirin + P2Y12 if stent <3 months; consult cardiology * At ≥12 months: Stop clopidogrel 5-7 days before; CONTINUE ASPIRIN throughout perioperatively * NO heparin bridging for antiplatelet therapy (increases bleeding without reducing stent thrombosis) - PERIOPERATIVE BETA-BLOCKER: continue (do NOT abruptly stop — rebound ischaemia) - ACE-i/ARB: hold on morning of surgery (hypotension risk); restart 24h post-op - Statins: CONTINUE perioperatively (pleiotropic effects, plaque stabilisation) - Monitoring: ECG lead II + V5, arterial line; consider TEE in high-risk - Regional vs GA: neuraxial/regional has cardiac benefits (↓ stress response, ↓ DVT); epidural for TKR/THR - Timing of neuraxial after stopping antiplatelet: clopidogrel 7 days, ticagrelor 5 days, prasugrel 7 days **SECTION 7: HYPERTENSION** 8. **Blood pressure — definition, accurate measurement, types** - DEFINITION: Arterial blood pressure = cardiac output × systemic vascular resistance - Normal: SBP <120, DBP <80 mmHg - ACCURATE MEASUREMENT: * Patient preparation: seated quietly 5 min, no caffeine/exercise for 30 min, empty bladder * Cuff size: width = 40% of arm circumference; length = 80% of arm circumference; wrong cuff = false reading * Auscultatory method: Korotkoff sounds: K1 = SBP, K5 = DBP (K4 in special cases) * At least 2 readings, 1-2 min apart; average used * Both arms initially; use higher reading arm * Orthostatic measurements if indicated - TYPES: * Essential (primary) hypertension: 90-95%; no identifiable cause * Secondary hypertension: 5-10%: renal (renovascular, parenchymal), endocrine (phaeochromocytoma, Conn's, Cushing's, hyperthyroidism), coarctation, OSA, drugs * White coat hypertension: elevated in clinic; normal on ABPM * Masked hypertension: normal in clinic; elevated on ABPM * Resistant hypertension: uncontrolled despite 3 drugs (including diuretic) * Hypertensive urgency: severe BP (>180/120) without end-organ damage * Hypertensive emergency: severe BP with end-organ damage (encephalopathy, STEMI, aortic dissection, AKI) - JNC 8 / ACC/AHA 2017 classification: Normal <120/80; Elevated 120-129/<80; Stage 1: 130-139/80-89; Stage 2: ≥140/≥90 - Perioperative: elective surgery if DBP >110 mmHg — postpone and optimise; SBP >180/DBP >110 = postpone **SECTION 8: VALVULAR HEART DISEASE — MITRAL STENOSIS** 9. **Pathophysiology of mitral stenosis** - Cause: Rheumatic fever (90%); calcification (elderly) - Normal MVA = 4-6 cm²; Mild MS >1.5 cm²; Moderate 1.0-1.5 cm²; Severe <1.0 cm² - Critical <0.6 cm² - HAEMODYNAMIC CASCADE: * ↑ mitral valve gradient → ↑ LAP → LA dilatation → AF (50%) → pulmonary venous hypertension → pulmonary arterial hypertension → RV failure → tricuspid regurgitation → right heart failure * Fixed cardiac output (CO depends on diastolic filling time) * Tachycardia: ↓ diastolic filling time → ↓ CO → ↑ LAP → flash pulmonary oedema - Gorlin formula: valve area = flow / (constant × √ mean gradient) - Haemodynamic goals: HR 60-80 (avoid tachycardia), NSR (maintain if possible), avoid ↑ pulmonary resistance (avoid hypoxia, hypercarbia, acidosis), adequate preload but avoid fluid overload 10. **Anaesthetic management of severe MS for LSCS** - Pre-op: optimize (diuretics, beta-blocker for rate control, digoxin/amiodarone if AF), assess functional class, echo for MVA and PAP - MODE OF ANAESTHESIA: Regional preferred (spinal carries risk of sudden hypotension — use low-dose/slow epidural preferred) - EPIDURAL: drug of choice — incremental dosing, slow onset, haemodynamically predictable - SPINAL: use with extreme caution; low-dose spinal + epidural (CSE with very low spinal dose) - Avoid: tachycardia (ketamine increases HR — avoid), aortocaval compression (left lateral tilt) - Vasopressors: PHENYLEPHRINE (pure alpha — maintains SVR without ↑ HR) preferred over ephedrine (which causes tachycardia) - INTRAOPERATIVE goals: HR 60-80, maintain sinus rhythm, adequate SVR, avoid pulmonary vasoconstrictors - OXYTOCIN: give SLOWLY (10 units over 15-20 min); rapid bolus → ↓ SVR → ↑ HR → flash pulmonary oedema; avoid ergometrine (causes coronary/pulmonary vasoconstriction, ↑ SVR) - Post-op: ICU monitoring; beware of fluid shifts 11. **Anaesthetic management of severe MS for emergency appendicectomy** - Emergency: cannot delay; optimise as far as possible in limited time - Pre-op: IV beta-blocker (esmolol/metoprolol) to control rate; diuretics if pulmonary congestion - ANAESTHESIA CHOICE: * Regional (spinal ± epidural) if coagulation normal, haemodynamics allow — avoids GA risks * GA if regional contraindicated: use ETOMIDATE (haemodynamically stable induction), avoid ketamine (↑ HR), careful opioid use - RSI considerations: modified RSI (avoid succinylcholine if K+ concerns); rocuronium + sugammadex - Maintain: HR <80, avoid hypotension, avoid ↑ pulmonary resistance - Vasopressors: phenylephrine - Monitoring: invasive arterial line, consider CVP - Post-op: HDU/ICU **SECTION 9: CARDIAC RISK ASSESSMENT** 12. **Risk assessment for IHD patient for non-cardiac surgery (Revised Cardiac Risk Index — RCRI)** - LEE'S RCRI (1999) — 6 independent predictors: 1. High-risk surgery (suprainguinal vascular, intrathoracic, intraperitoneal) 2. History of ischemic heart disease 3. History of congestive heart failure 4. History of cerebrovascular disease 5. Insulin-dependent diabetes 6. Preoperative serum creatinine >2.0 mg/dL - RISK: Score 0 = 0.4%, Score 1 = 1%, Score 2 = 2.4%, Score 3+ = 5.4% major cardiac event - ACC/AHA STEPWISE ALGORITHM: 1. Emergency? → No time for evaluation, proceed with monitoring 2. Active cardiac conditions? (ACS, decompensated HF, severe valvular disease, significant arrhythmia) → stabilise first 3. Low-risk surgery? (MACE risk <1%: superficial, endoscopic, cataract, breast) → proceed 4. Functional capacity ≥4 METs? → can proceed without further testing (climb 2 flights, walk on level ground at 4mph) 5. Clinical risk factors: use RCRI; if ≥3 factors + high-risk surgery → consider stress testing/optimisation 13. **Frail elderly with diastolic dysfunction — perioperative concerns** - Diastolic dysfunction grades (ACC/AHA echocardiographic criteria) - Implications: stiff LV, filling pressure-dependent, sensitive to tachycardia, preload, afterload - Haemodynamic goals: maintain sinus rhythm, HR 60-70, adequate preload (Starling), avoid tachycardia and SVT - Drugs: spironolactone, ACE-i/ARB for structural reverse remodelling - Perioperative: avoid fluid overload AND fluid deficit; invasive monitoring (arterial line); CVP/TEE-guided **SECTION 10: NON-INVASIVE CARDIAC OUTPUT MONITORING** 14. **Non-invasive cardiac output monitoring methods** - THORACIC BIOIMPEDANCE (TBI): measures ΔZ (change in electrical impedance of thorax with cardiac cycle); CO = formula using ΔZ, weight, height, HR; affected by oedema, pleural effusion - BIOREACTANCE (NICOM): measures phase shifts in current; less affected by tissue fluid than bioimpedance; validated in critical care - OESOPHAGEAL DOPPLER (ODM — CardioQ): semi-invasive probe; measures descending aortic flow velocity; Doppler waveform = stroke volume, corrected flow time (FTc); real-time fluid responsiveness; validated for goal-directed fluid therapy in surgical patients - PULSE CONTOUR ANALYSIS (Flotrac/Vigileo, PiCCO): analyses arterial waveform morphology for CO; requires arterial line (minimally invasive); continuous CO; Flotrac = uncalibrated; PiCCO requires calibration (TPTD) - USCOM (Ultrasonic Cardiac Output Monitor): transcutaneous Doppler; suprasternal notch probe - NICO (non-invasive CO): partial CO2 rebreathing method (Fick principle with CO2); requires intubation; not truly non-invasive - PLETHYSMOGRAPHY VARIABILITY INDEX (PVI): pulse oximeter-derived; respiratory variation in plethysmographic waveform; fluid responsiveness indicator - PPV (Pulse Pressure Variation): arterial line + mechanical ventilation; >13% = fluid responsive **SECTION 11: TEE** 15. **Role of TEE in cardiac anaesthesia** - INDICATIONS (ASE/SCA Guidelines): Category A (supported by evidence): valve surgery, congenital heart surgery, LVAD insertion, pericardial surgery, aortic surgery, endocarditis complications Intraoperative haemodynamic instability unexplained by clinical data - KEY INFORMATION FROM TEE: * Ventricular function: LV/RV systolic and diastolic function, EF (Simpson's biplane), RWMA * Valvular: severity of regurgitation/stenosis, vegetations, repair assessment post-bypass * Aorta: atheroma, dissection, aneurysm * Intracardiac: thrombus (LAA), air embolism detection, ASD/VSD/PFO * Haemodynamics: filling pressures (estimated), tamponade (RA/RV collapse) * Post-bypass: assess adequacy of repair, residual lesions, new RWMA - VIEWS: 5 standard windows: transgastric (mid-papillary SAX best for circumferential LV function), mid-oesophageal (4-chamber, 2-chamber, LAX), deep transgastric (LVOT), upper oesophageal (aortic arch) - CONTRAINDICATIONS: oesophageal stricture/cancer/varices, recent oesophageal surgery, active GI bleed - ADVANTAGES over TTE: superior image quality in intubated/obese patients; continuous monitoring **SECTION 12: CPET** 16. **Perioperative cardiopulmonary exercise testing (CPET)** - PRINCIPLE: Integrated response of cardiac, pulmonary, and muscular systems to incremental exercise - KEY PARAMETERS: * VO2 max (peak O2 consumption): <15 mL/kg/min = high risk; >20 = low risk * Anaerobic Threshold (AT/VT1): O2 uptake at which anaerobic metabolism begins; <11 mL/kg/min = high risk for major surgery; >11 = intermediate; >14 = low risk * VE/VCO2 slope: >35 = high risk (poor ventilatory efficiency; reflects pulmonary HTN, HF) * O2 pulse (VO2/HR): surrogate for stroke volume; flat response = cardiac limitation - INDICATIONS: pre-op assessment for: major abdominal surgery (oesophagectomy, hepatic resection), thoracic surgery, TAVI pre-assessment, cardiac transplant listing, lung transplant assessment - CONTRAINDICATIONS: unstable angina, recent MI (<1 month), uncontrolled HF, severe AS, uncontrolled arrhythmia, severe HTN (SBP >200), unable to exercise - PROTOCOL: Ramp cycle ergometry; continuous 12-lead ECG, breath-by-breath spirometry - ALTERNATIVE: 6-minute walk test (<350m = poor functional capacity), Duke Activity Status Index (DASI) **SECTION 13: VENOUS AIR EMBOLISM** 17. **VAE — Causes, pathophysiology, paradoxical air embolism, capnography, management** - CAUSES: * Venous: sitting craniotomy (most common neurosurgical), open cardiac surgery, central line insertion/removal, hip arthroplasty, liver transplant, laparoscopy (CO2 though), C-section, laser hysteroscopy, any open vein above heart level * Arterial air embolism: iatrogenic (arterial line, cardiac surgery), paradoxical via PFO - DETECTION SENSITIVITY ORDER (most → least sensitive): 1. TOE (TEE): detects 0.02 mL/kg 2. Precordial Doppler: detects 0.25 mL; hissing/roaring sound; standard of care 3. Pulmonary artery pressure: rises 4. ETCO2: SUDDEN ↓ (↑ dead space) — practical, continuous, already on all patients 5. CVP: rises 6. BP/ECG/mill-wheel murmur: very late signs - PATHOPHYSIOLOGY: air in RV → air lock → obstruction of RVOT → ↓ CO; air reaches pulmonary vessels → ↑ PVR; massive air → cardiac arrest - PARADOXICAL AIR EMBOLISM: air crosses from right to left heart via PFO (present in 25% of adults) or ASD → systemic circulation → stroke, coronary occlusion, end-organ ischaemia; occurs when RAP > LAP (large VAE event, PEEP) - CAPNOGRAPHY in VAE: air in pulmonary vasculature → ↑ physiological dead space (no perfusion) → ↓ ETCO2; ETCO2 drop precedes haemodynamic compromise; gradient between ETCO2 and PaCO2 widens - MANAGEMENT: 1. Notify surgeon; FLOOD FIELD with saline; pack wound; bone wax on skull edges 2. Bilateral jugular venous compression 3. Discontinue N2O → FiO2 1.0 (N2O expands air bubbles) 4. Lower surgical site / head down (if possible) 5. Aspirate right heart catheter (multiorificed tip at SVC-RA junction) 6. Vasopressors + volume loading 7. NO PEEP (increases PAE risk via PFO) 8. Durant's manoeuvre: left lateral decubitus + Trendelenburg → moves air away from RVOT 9. CPR if arrest; hyperbaric oxygen for neurological injury **SECTION 14: OBSTETRIC CARDIAC** 18. **Aortocaval compression** - Mechanism: gravid uterus ≥20 weeks compresses IVC (80-90% reduction in venous return) and aorta in supine position - Results: ↓ venous return → ↓ preload → ↓ CO → hypotension (supine hypotension syndrome in 10% symptomatic, 80% subclinical) - PREVENTION: Left lateral uterine displacement (LUD) 15-30° (wedge under right hip) - Manual LUD by assistant during CPR in pregnancy - Significance in spinal anaesthesia for CS: pre-loading + LUD + phenylephrine infusion 19. **Severe MS in pregnancy for LSCS** — (covered in Section 8 above — refer to Q10) **SECTION 15: CONGENITAL HEART DISEASE** 20. **Cyanotic and acyanotic congenital heart disease** - ACYANOTIC (L→R shunts initially, no cyanosis): * VSD (most common CHD overall — 32%): pansystolic murmur; Eisenmenger if large * ASD (most common in adults): fixed split S2; types: ostium secundum (70%), primum (30%), sinus venosus * PDA: continuous machinery murmur; treat with indomethacin (preterm) or surgical ligation * Coarctation of aorta: upper limb hypertension, weak femoral pulses, rib notching on CXR * Pulmonary stenosis: ejection systolic murmur, right ventricular hypertrophy * Aortic stenosis (congenital bicuspid valve) - CYANOTIC (R→L shunts, cyanosis from birth or early): * TOF (most common cyanotic CHD): 4 components = VSD + RVOTO + overriding aorta + RVH; tet spells (hypercyanotic); squat to ↑ SVR; treat spell with O2 + knee-chest + phenylephrine + beta-blocker * TGA (D-TGA): aorta arises from RV, PA from LV; parallel circuits; needs mixing (ASD/PDA/VSD) for survival; balloon atrial septostomy at birth; arterial switch operation * Tricuspid atresia: absent TV; single ventricle physiology; Fontan procedure * TAPVD (Total anomalous pulmonary venous drainage): all PVs drain to right heart; requires mixing at ASD * Truncus arteriosus: single great artery giving rise to aorta + PA; early Eisenmenger risk * Ebstein anomaly: displaced tricuspid valve (atrialized RV); WPW association; TR, cyanosis - Eisenmenger syndrome: reversal of shunt (L→R → R→L) due to pulmonary hypertension **SECTION 16: IVC COLLAPSIBILITY INDEX** 21. **IVC collapsibility index** - MEASUREMENT: M-mode or 2D ultrasound; subcostal window; measure IVC 2 cm from RA junction - FORMULA: IVC-CI = (IVCmax - IVCmin) / IVCmax × 100% - Where: IVCmax = diameter at end-expiration; IVCmin = diameter at peak inspiration (sniff test) - INTERPRETATION (spontaneously breathing patients): * IVC-CI >50%: low RAP (<8 mmHg) → likely fluid responsive * IVC-CI <50%: higher RAP → less likely fluid responsive - DISTENSIBILITY INDEX (mechanically ventilated): (IVCmax - IVCmin) / IVCmin >18% = fluid responsive - NORMAL IVC diameter: 1.5-2.5 cm (adults) - LIMITATIONS: * Spontaneous breathing vs mechanical ventilation (different thresholds) * Tricuspid regurgitation: IVC plethoric regardless of volume status * RV failure: dilated IVC despite adequate filling * Raised intraabdominal pressure (obese, pregnancy, ascites): IVC compressed → false high collapsibility * Operator-dependent; poor acoustic window in obese patients * Open chest surgery: IVC pressure changes unreliable - CLINICAL USE: Volume responsiveness assessment, guide fluid therapy in ICU/ED/OT SEARCH INSTRUCTIONS: - SQL: SELECT title, book_title, '/textbooks/' || block_file_path AS file_path, line_number, para_line_ranges FROM headings_fts WHERE headings_fts MATCH 'transesophageal echocardiography cardiac surgery' ORDER BY rank LIMIT 5 - Also use paragraphs_fts for specific facts - Read actual file content - Provide clear subheadings, tables, mnemonics - Include drug doses throughout Return comprehensive, well-structured answers for ALL topics suitable for DNB theory exam cardiac anaesthesia.
Try again from stoeltings only